摘要
目的分析托拉塞米联合卡托普利治疗慢性舒张性心力衰竭的临床疗效。方法将医院2016年1—10月收治的128例慢性舒张性心力衰竭患者以随机原则分为两组,每组64例,常规组单用托拉塞米治疗,实验组予以托拉塞米联合卡托普利治疗,对两组临床疗效作回顾性分析与比较。结果治疗3个月后,实验组临床总有效率为96.88%,高于常规组的总有效率82.81%,组间差异具有统计学意义(P<0.05);实验组治疗后心率明显下降,LEVE、6 min步行试验指标升高,组间差异具有统计学意义(P<0.05)。结论托拉塞米联合卡托普利用于治疗慢性舒张性心力衰竭,能有效抑制纤维化,缓解心衰症状,改善心功能,提高患者生存质量,临床疗效确切。
Objective To analyze the clinical efficacy of torasemide combined with captopril in the treatment of chronic diastolic heart failure. Methods From January to October 2016, 128 cases of chronic diastolic heart failure were randomly divided into two groups, 64 Cases in each group. The routine group was treated with torasemide treatment, experimental group received torasemide combined with captopril. The clinical efficacy of the two groups were retrospectively analyzed and compared. Results After 3 months of treatment, the total effective rate in experimental group was 96.88%, higher than that of routine treatment group the total effective rate was 82.81%%, the difference was statistically significant between the two groups (P〈0.05). Heart rate was significantly decreased after treatment in the study, LEVE, 6 min walk test increased, the difference was statistically significant between the two groups (P〈0.05). Conclusion Torasemide combined with captopril for the treatment of chronic diastolic heart failure Can effectively inhibit the fibrosis and ease the symptoms of heart failure and improve the cardiac function and improve the quality of life of patients, the clinical curative effect is good.
作者
夏银稳
XIA Yinwen(Department of Cardiology, Hanchuan People's Hospital. Hanchuan Hubei 431600, China)
出处
《中国继续医学教育》
2017年第9期193-194,共2页
China Continuing Medical Education
关键词
托拉塞米
卡托普利
慢性舒张性心力衰竭
疗效
torasemide
captopril
chronic diastolic heart failure
curative effect